Supplemental material
Drug Delivery
Volume 26, 2019 - Issue 1
Related Research Data
Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice
Source:
Springer Nature
Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
Source:
Informa UK Limited
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
Source:
Elsevier BV
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
Source:
Springer Science and Business Media LLC
Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Source:
Elsevier BV
Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Source:
Informa UK Limited
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.
Source:
Elsevier BV
Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect.
Source:
Elsevier BV
Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Source:
Informa UK Limited
BCS class IV drugs: Highly notorious candidates for formulation development.
Source:
Elsevier BV
Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors.
Source:
Springer Science and Business Media LLC
Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS)
Source:
Informa UK Limited
Linking provided by
